The pharmaceutical sector is involved in all phases of R&D, but it contributes the most to translating and applying knowledge to product development. Industry pays for the majority of the clinical trials required for market authorization. Research and development are one of the most significant aspects of the pharmaceutical industry. The pharmaceutical industry invests heavily on research and development. Higher drug prices can both cause and result in rising R&D expenses, as payer approval of higher pricing can make increasingly costly R&D and acquisitions of R&D projects financially viable. Increased R&D and acquisition expenditures might lead to price increases.
Title : Engineered nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Preparation and characterization of fibers made from PCL/PVP-ChAgG, along with exploring their potential as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Liver biopsy handling of metabolic-associated fatty liver disease (mafld): The children's hospital of eastern ontario grossing protocol
Consolato M Sergi, University of Ottawa, Canada
Title : Haptoglobin-related protein without signal peptide as biomarker of renal salt wasting (HPRWSP) in hyponatremia, hyponatremia-related diseases and as new syndrome in alzheimer’s disease
John K Maesaka, NYU Langone Hospital Long Island, United States